Irma Bagdoniene: Extreme Lipoprotein(a) Equals Secondary Prevention Risk in FH Patients
Irma Bagdoniene, Cardiologist and Lipidologist at Klinikum Lippe – University Hospital for Cardiology, Angiology, and Internal Intensive Care Medicine, posted on LinkedIn:
“This study highlights a important message: patients with extreme elevations of Lp(a) already carry a cardiovascular risk equivalent to secondary prevention — even in the primary prevention setting.
Implications for clinical practice:
- LDL-C targets of ≤70 mg/dL, ideally ≤55 mg/dL, are fully justified.
- Achieving these levels often requires combination therapy, including PCSK9 inhibitors.
- These high-risk patients deserve early, intensive lipid management—not only after their first event.
A strong reminder: FH AND extreme Lp(a) is a double-hit dyslipidemia that demands aggressive and early prevention strategies.”
Title: Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemia
Authors: Martine Paquette, MSca, Bertrand Cariou, MDb, Simon-Pierre Guay, MDa,c,d, Antonio Gallo, MDe, Liam R. Brunham, MDf, Sophie Béliard, MDg, Alexis Baass, MD
Read full article here.
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch